SeaStar Medical Holding Corporation (ICUCW)Denver, United States | NasdaqCM
0.02 USD
0.00
(-4.878%) ⇩
(Oct. 13, 2026, 3:40 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 9:15 a.m. EDT
The security is trapped in a death spiral with negligible liquidity and catastrophic fundamentals. Despite reporting an impressive 82% revenue growth, the company is hemorrhaging cash with operating losses exceeding 6 million and negative free cash flow, while returning -3.5% on equity. The balance sheet is fragile with a debt-to-equity ratio over 3, and the market has priced this out to a fraction of book value (P/B of 0.015), reflecting a consensus view of imminent failure rather than a bargain. With zero analyst coverage, no institutional interest, and a trading volume so thin it barely registers, there is no capital left to drive a recovery. The recent news headlines describe volatile intraday moves, but these are merely noise in a vacuum where the underlying business model is failing. There is no safe entry here. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 3.119 |
| Revenue per Share | 0.479 |
| Beta | -1.07 |
| Previous Name | LMF Acquisition Opportunities, Inc. |
| Website | https://seastarmedical.com |
| Attribute | Value |
|---|---|
| Address1 | 3,513 Brighton Boulevard |
| Address2 | Suite 410 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | -1.066 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 1.008 |
| City | Denver |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0156 |
| Current Ratio | 1.89 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0183 |
| Day Low | 0.0156 |
| Debt To Equity | 3.119 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0183 |
| Fifty Two Week High Change | -0.002700001 |
| Fifty Two Week High Change Percent | -0.14754103 |
| Fifty Two Week Low | 0.0156 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.0156 - 0.0183 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 4,368,325 |
| Free Cashflow | -9,141,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 18 |
| Fullday Change | -0.0008000005 |
| Fullday Change Percent | -4.8780518 |
| Fullday Price | 0.0156 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.92644 |
| Gross Profits | 1,587,000 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado. |
| Long Name | SeaStar Medical Holding Corporation |
| Market | us_market |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_111447 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -13,627,000 |
| Open | 0.0375 |
| Operating Cashflow | -13,693,000 |
| Operating Margins | -6.16423 |
| Phone | 844 427 8100 |
| Prev Name | LMF Acquisition Opportunities, Inc. |
| Previous Close | 0.0164 |
| Price Hint | 4 |
| Price To Book | 0.01547619 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.646 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0008000005 |
| Regular Market Change Percent | -4.8780518 |
| Regular Market Day High | 0.0183 |
| Regular Market Day Low | 0.0156 |
| Regular Market Day Range | 0.0156 - 0.0183 |
| Regular Market Open | 0.0375 |
| Regular Market Previous Close | 0.0164 |
| Regular Market Price | 0.0156 |
| Regular Market Time | 1,791,920,449 |
| Regular Market Volume | 20,027 |
| Return On Assets | -1.02667 |
| Return On Equity | -3.56868 |
| Revenue Growth | 0.82 |
| Revenue Per Share | 0.479 |
| Sand P52 Week Change | 0.17502642 |
| Sector | |
| Sector Key | |
| Source Interval | 15 |
| State | CO |
| Symbol | ICUCW |
| Total Cash | 6,959,000 |
| Total Cash Per Share | 1.579 |
| Total Debt | 134,000 |
| Total Revenue | 1,713,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 20,027 |
| Website | https://seastarmedical.com |
| Zip | 80,216 |